Engelbert Willink
Director/Board Member chez B&S GROUP S.A.
Profil
Engelbert Tjeenk Willink is currently the Chairman at Biosanapharma BV and the Vice Chairman-Supervisory Board at B&S Group SA. Previously, he held positions such as Chairman-Executive Board at STADA Arzneimittel AG in 2017, Chairman at Allecra Therapeutics GmbH, Director-Marketing & Sales Human Pharma at Boehringer Ingelheim GmbH from 2011 to 2012, Managing Director at Boehringer Ingelheim Corp., and Director at Boehringer Ingelheim AB.
Postes actifs de Engelbert Willink
| Sociétés | Poste | Début |
|---|---|---|
| B&S GROUP S.A. | Director/Board Member | 30/12/2022 |
Biosanapharma BV
 Biosanapharma BV Pharmaceuticals: MajorHealth Technology Biosanapharma BV is a Dutch pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Leiden, Netherlands. The CEO of the company is Ard Tijsterman. | Chairman | - |
Anciens postes connus de Engelbert Willink
| Sociétés | Poste | Fin |
|---|---|---|
| STADA ARZNEIMITTEL | Chief Executive Officer | 27/09/2017 |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Director/Board Member | 31/12/2012 |
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Chairman | - |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Director/Board Member | 15/07/2011 |
Boehringer Ingelheim AB
 Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| B&S GROUP S.A. | Distribution Services |
| Entreprise privées | 6 |
|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Boehringer Ingelheim AB
Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Health Technology |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Health Technology |
Biosanapharma BV
Biosanapharma BV Pharmaceuticals: MajorHealth Technology Biosanapharma BV is a Dutch pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Leiden, Netherlands. The CEO of the company is Ard Tijsterman. | Health Technology |
